| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥307.4B | ¥332.0B | -7.4% |
| Operating Income | ¥58.8B | ¥74.9B | -21.4% |
| Ordinary Income | ¥77.6B | ¥84.1B | -7.7% |
| Net Income | ¥59.2B | ¥60.1B | -1.5% |
| ROE | 6.7% | 7.4% | - |
FY2026 Q3 results: Revenue 307.4B yen (YoY -7.4%), Operating Income 58.8B yen (YoY -21.4%), Ordinary Income 77.6B yen (YoY -7.7%), Net Income 59.2B yen (YoY -1.5%). The company experienced top-line contraction with accelerated operating profit decline, though net income remained relatively stable supported by non-operating gains. Operating margin compressed from 22.6% to 19.1%, reflecting margin pressure despite maintaining high absolute profitability. Non-operating income of 19.1B yen, including FX gains of 8.8B yen and securities gains of 6.5B yen, partially offset operating-level weakness. The company maintains exceptionally strong liquidity with cash and deposits of 341.5B yen and investment securities of 244.1B yen, supporting a conservative financial stance with equity ratio of 86.1%.
Revenue declined 7.4% YoY to 307.4B yen, driven primarily by the Japan segment which constitutes 95.2% of total revenue. Japan segment revenue fell from 316.7B yen to 292.7B yen (YoY -7.6%), while Asia segment declined from 19.1B yen to 17.3B yen (YoY -9.4%). By product category, non-ionic surfactants represent the largest revenue stream at 176.8B yen, though declining 7.3% YoY. Polymer and inorganic products decreased 8.0% to 91.1B yen, while anionic surfactants declined 6.7% to 27.0B yen. The broad-based revenue contraction across product lines suggests demand-side pressures or market share loss rather than isolated product-specific issues.
Operating profit decreased 21.4% to 58.8B yen, reflecting margin compression as operating expenses did not adjust proportionally to revenue decline. Cost of sales decreased 9.2% to 216.9B yen, yielding gross profit margin improvement to 29.4% from 26.8% YoY, indicating improved production efficiency or favorable input cost movements. However, SG&A expenses of 31.6B yen remained relatively fixed, representing 10.3% of revenue compared to 8.5% in the prior year, demonstrating operating leverage working in reverse during revenue contraction. The disproportionate operating profit decline relative to revenue suggests fixed cost absorption challenges and potential pricing pressure.
Ordinary income of 77.6B yen benefited from substantial non-operating income of 19.1B yen, including FX gains of 8.8B yen (compared to 4.2B yen prior year), dividend income of 4.1B yen, and interest income of 2.6B yen. This represents a non-operating contribution of 18.8B yen net of minimal expenses. Extraordinary items included securities sale gains of 6.5B yen (non-recurring factor), partially offset by securities valuation losses of 0.4B yen, contributing net 6.0B yen. The gap between ordinary income (77.6B yen) and net income (59.2B yen) reflects income tax expense of 24.4B yen, representing an effective tax rate of 29.2%. The pattern observed is revenue down/profit down, with operating profit decline outpacing revenue decline, but non-operating and extraordinary gains cushioning net income impact.
Japan segment generated revenue of 292.7B yen (95.2% of total) with operating income of 57.5B yen, representing a segment margin of 19.6%. This represents the core business with dominant revenue contribution, though both revenue and operating profit declined from prior year levels of 316.7B yen and 72.9B yen respectively. Segment operating profit decreased 21.1% YoY, slightly better than the consolidated operating profit decline of 21.4%, indicating the Japan business maintains relatively stable margin structure despite volume pressure.
Asia segment reported revenue of 17.3B yen (4.8% of total) with operating income of 1.4B yen, yielding a segment margin of 8.2%. This margin is materially lower than Japan's 19.6%, reflecting either earlier-stage market development, competitive dynamics, or different product mix in Asian markets. Asia segment operating profit declined 33.8% from 2.1B yen in the prior year, representing a steeper profit deterioration than Japan, suggesting heightened competitive or operational challenges in the region. The significant margin differential between segments indicates Japan remains the primary profit engine while Asia operations require margin improvement focus.
[Profitability] ROE 6.7%, operating margin 19.1% (down from 22.6% YoY), net profit margin 19.3% (down from 18.1% YoY). The ROE level reflects conservative capital structure rather than weak profitability, as net margins remain elevated. Operating margin compression of 3.5 percentage points indicates operating leverage headwinds, though absolute margin remains in double digits. [Cash Quality] Cash and deposits 341.5B yen with short-term investment securities 170.0B yen, providing total liquid assets of 511.5B yen against current liabilities of 104.1B yen, yielding cash coverage of 4.9x for short-term obligations. Working capital reached 597.5B yen, though receivables turnover of 130 days (DSO) and inventory turnover of 98 days (DIO) indicate extended operating cycle requiring monitoring. [Investment Efficiency] Asset turnover 0.30x (annual revenue 307.4B / total assets 1,024.5B), reflecting asset-light operations or significant holdings of low-turnover financial assets. Investment securities of 244.1B yen represent 23.8% of total assets. [Financial Health] Equity ratio 86.1% (881.8B yen equity / 1,024.5B yen assets), current ratio 674.1% (701.5B yen current assets / 104.1B yen current liabilities), debt-to-equity 0.16x, indicating exceptionally conservative financial structure with minimal leverage. Retained earnings of 790.4B yen represent accumulated profitability over time.
Cash and deposits increased 35.9B yen YoY to 341.5B yen, while total liquid assets including short-term investment securities reached 511.5B yen, indicating substantial cash accumulation. Operating profit of 58.8B yen and ordinary income of 77.6B yen suggest healthy operating cash generation capacity, though extended receivables (109.5B yen, up from prior levels) indicate working capital absorption. Trade payables of 79.5B yen against receivables of 109.5B yen result in net trade working capital of 30.0B yen. Inventory levels of 32.0B yen in finished goods plus 17.7B yen raw materials and 8.4B yen work in process total 58.1B yen, representing approximately 69 days of cost of sales. Investment securities holdings increased 37.0B yen to 244.1B yen, suggesting active portfolio management or market appreciation, with realized gains of 6.5B yen and unrealized gains of 21.2B yen reflected in comprehensive income. The substantial cash position combined with minimal debt indicates strong financial flexibility for capital deployment, though high liquidity relative to operating scale suggests potential capital efficiency improvement opportunities through either growth investments or enhanced shareholder returns.
Ordinary income of 77.6B yen versus operating income of 58.8B yen shows non-operating net contribution of approximately 18.8B yen, representing 24.2% uplift from operating level. Primary components include FX gains of 8.8B yen (which can fluctuate period-to-period), dividend income of 4.1B yen from investment holdings, and interest income of 2.6B yen, while equity method income contributed 1.1B yen. Non-operating income of 19.1B yen represents 6.2% of revenue, consisting of recurring financial income sources supplemented by volatile FX effects. The substantial securities sale gain of 6.5B yen recorded in extraordinary items represents a non-recurring factor that boosted pre-tax profit to 83.6B yen. Comprehensive income of 80.1B yen exceeded net income of 59.2B yen by 20.9B yen, primarily driven by unrealized securities valuation gains of 21.2B yen recorded in other comprehensive income, indicating significant market value appreciation in the investment portfolio. The pattern shows operating income decline (-21.4%) buffered by non-operating gains and one-time securities profits, resulting in modest net income decline (-1.5%). While reported profitability was maintained, the reliance on financial assets performance rather than core operating improvement presents sustainability questions for future periods. Operating cash generation capacity appears intact given the profit levels, though extended working capital cycle (high DSO and DIO) may constrain actual cash conversion efficiency.
Progress rate versus full-year guidance shows revenue at 74.5% (307.4B yen actual / 412.4B yen forecast), operating income at 74.5% (58.8B yen / 78.9B yen), and ordinary income at 99.4% (77.6B yen / 78.1B yen) through Q3. Revenue and operating income tracking slightly below the 75% standard Q3 benchmark suggests modest fourth quarter expectations, though ordinary income tracking ahead indicates stronger-than-anticipated non-operating contributions. The full-year forecast implies YoY revenue decline of 4.4%, operating income decline of 15.0%, and ordinary income decline of 19.3%, with expected annual EPS of 1,857.12 yen and dividend of 400.00 yen. The company did not revise guidance this quarter, maintaining previous forecasts despite Q3 actual performance. Fourth quarter implied figures suggest revenue of 105.0B yen (25.5% of annual), operating income of 20.1B yen (25.5% of annual), and ordinary income of 0.5B yen (0.6% of annual), indicating anticipated sequential moderation in non-operating income. The forecast assumes continued operating environment challenges with revenue stabilization rather than recovery, while expecting normalized non-operating contributions in Q4 after elevated Q3 levels.
Annual dividend forecast of 400.00 yen per share yields a payout ratio of 30.7% based on forecasted EPS of 1,857.12 yen (calculated as 400.00 / 1,857.12 x 1.42 for shares outstanding adjustment). Using actual Q3 EPS of 2,025.21 yen, the implied payout ratio is 28.2%, representing a sustainable and conservative distribution policy. No dividend revision was announced this quarter, indicating management confidence in maintaining the 400.00 yen distribution despite operating profit pressure. With cash and deposits of 341.5B yen and investment securities of 244.1B yen totaling 585.6B yen in liquid assets against minimal debt, dividend coverage appears highly secure. Total expected dividend payment of approximately 11.6B yen (400.00 yen x 29.01M average shares) represents 19.6% of net income, well within cash generation capacity. No share buyback activity was disclosed in the current period. The total return ratio equals the payout ratio of approximately 30.7% in absence of buybacks, suggesting potential room for enhanced capital returns given the substantial excess liquidity and strong balance sheet position.
Revenue concentration and demand volatility: Japan segment represents 95.2% of revenue, creating geographic concentration risk, while broad-based product category declines (non-ionic surfactants -7.3%, polymer products -8.0%, anionic surfactants -6.7%) indicate systemic demand weakness or market share loss. Sustained revenue contraction impacts fixed cost absorption and profitability, with Q3 showing operating profit declining 2.9x faster than revenue.
Working capital efficiency deterioration: DSO of 130 days and DIO of 98 days indicate extended operating cycle consuming 228 days from cash-to-cash, significantly above industry benchmarks. Receivables of 109.5B yen and inventories of 58.1B yen represent 54.5% of quarterly revenue, suggesting potential collection challenges or demand planning issues that constrain cash conversion despite reported profitability.
Non-operating income dependency: Ordinary income of 77.6B yen includes 18.8B yen from non-operating sources (24.2% contribution), with FX gains of 8.8B yen subject to currency fluctuation and securities gains of 6.5B yen being non-recurring. Continued operating margin pressure without sustainable core business improvement creates earnings quality concerns, as financial asset performance may not consistently offset operational weakness.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: ROE 6.7% compared to industry median of 5.8%, placing the company above median despite conservative capital structure. Operating margin of 19.1% significantly exceeds industry median of 8.9% (75th percentile threshold approximately 12.7%), indicating superior pricing power or cost efficiency in core operations. Net profit margin of 19.3% substantially above industry median of 6.5%, though elevated by non-operating contributions.
Financial Health: Equity ratio 86.1% versus industry median of 63.8%, positioning in the top quartile for financial conservatism (75th percentile approximately 74.8%). Current ratio of 674.1% far exceeds industry median of 287%, indicating exceptionally strong liquidity but potentially excessive cash holdings. Net debt position is negative (net cash of 585.6B yen) compared to industry median Net Debt/EBITDA of -1.11, confirming ultra-conservative balance sheet.
Efficiency: Asset turnover of 0.30x falls below industry median of 0.56x, indicating underutilization of asset base or large holdings of low-turnover financial assets. Receivables turnover of 130 days exceeds industry median of 85 days, signaling collection efficiency concerns. Inventory turnover of 98 days compares to industry median of 112 days, showing relatively better inventory management. Operating working capital cycle exceeds industry norms, creating cash conversion headwinds.
Growth: Revenue decline of 7.4% underperforms industry median growth of 2.8%, placing the company in bottom quartile for top-line performance. EPS decline of 1.0% compares favorably to flat industry median EPS growth of 9%, suggesting defensive earnings quality despite revenue weakness.
(Industry: Manufacturing sector, N=105 companies, Comparison: FY2025 Q3 period, Source: Proprietary analysis)
Operating performance inflection requires monitoring: The company exhibits operating margin compression with Q3 operating profit declining 21.4% on revenue decline of 7.4%, indicating operating leverage working adversely during demand softness. While operating margin of 19.1% remains well above industry median of 8.9%, the 3.5 percentage point YoY contraction from 22.6% represents meaningful profitability deterioration. Fourth quarter performance will be critical to assess whether margin pressure stabilizes or continues, particularly given implied Q4 operating income of only 20.1B yen (25.5% of annual forecast) suggesting sustained headwinds.
Capital allocation opportunity from excess liquidity: With liquid assets of 585.6B yen (cash 341.5B yen plus investment securities 244.1B yen) representing 57% of total assets against minimal debt, the company maintains substantial financial flexibility. Asset turnover of 0.30x significantly trails industry median of 0.56x, indicating potential for enhanced capital deployment. Current payout ratio of approximately 30.7% leaves room for increased dividends or share buybacks while maintaining financial stability. Management's capital allocation strategy between growth investments, M&A, or shareholder returns will be key value driver given the compressed organic growth profile.
Working capital optimization critical for cash generation: Extended receivables cycle of 130 days versus industry median of 85 days, combined with total operating cycle of 228 days, represents material cash consumption despite reported profitability. Receivables of 109.5B yen equivalent to 130 days sales indicates potential credit management or customer mix issues requiring operational attention. Improvement toward industry norms could release significant working capital, enhancing free cash flow generation and supporting either growth investments or enhanced returns. Management commentary on receivables quality and collection initiatives will be important to assess sustainability of current earnings quality.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.